Amgen (AMGN) Change in Acquisitions & Divestments (2009 - 2023)

Amgen (AMGN) has reported Change in Acquisitions & Divestments for 15 consecutive years, with -$575.0 million the latest figure, recorded in Q3 2023.

• In Q3 2023, Change in Acquisitions & Divestments fell 1123.4% year-over-year to -$575.0 million; the TTM figure through Jun 2024 stood at -$575.0 million (down 126.16% YoY), while the FY2023 annual figure was $550.0 million, down 50.89% from the prior year.
• Change in Acquisitions & Divestments came in at -$575.0 million for Q3 2023 at Amgen, down from $1.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $18.2 billion in Q3 2019, with the low at -$9.6 billion in Q4 2019.
• Average Change in Acquisitions & Divestments over 5 years is $1.3 billion, with a median of $904.0 million recorded in 2021.
• The largest YoY upside for Change in Acquisitions & Divestments was 1959.2% in 2020 against a maximum downside of 2639.13% in 2020.
• Year by year, Change in Acquisitions & Divestments stood at -$9.6 billion in 2019, then surged by 124.58% to $2.4 billion in 2020, then slumped by 61.68% to $904.0 million in 2021, then increased by 23.89% to $1.1 billion in 2022, then slumped by 151.34% to -$575.0 million in 2023.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$575.0 million, $1.0 million, and $1.1 billion for Q3 2023, Q2 2023, and Q1 2023 respectively.